Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q2 2026)
13,778
Value
$5.88K
% of portfolio
<0.1%
Quarters held
5
Since Q2 2025
Holdings of HRTX by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,778$5.88K<0.1%+43+0.3%AddedHolders
Q1 202613,735$11.0K<0.1%+1,842+15.5%AddedHolders
Q4 202511,893$15.5K<0.1%00.0%UnchangedHolders
Q3 202511,893$15.0K<0.1%00.0%UnchangedHolders
Q2 202511,893$24.6K<0.1%+11,893NewHolders